Zentek has redefined its operating model with a disciplined capital allocation framework, linking future financing to evidence-based milestones across its core platforms: Albany Graphite, ZenGUARD™ coatings and Triera. The Company is reducing its cost base, pausing or winding down non-core initiatives and engaging with regulatory authorities to ensure a streamlined path to sustainable value creation.

Recent independent laboratory results confirm Albany’s ultra-high-purity graphite can be refined to 5N (99.9992%) with just 2.60 ppm boron, meeting sub-3 ppm requirements for nuclear applications. Zentek plans to update its Preliminary Economic Assessment using current cost and technical data, scale up pilot processing to generate commercial-grade samples, and advance environmental and social baseline studies with the Constance Lake First Nation, all aimed at de-risking the project ahead of a potential spin-out or partnership within 12–18 months.

Building on its IP-rich coatings business, Zentek is integrating ultra-pure graphite into its development-on-demand model to address performance, regulatory and cost challenges for filtration, ice-phobic, fire-retardant and antimicrobial applications. The Company intends to expand contract R&D offerings by combining ZenGUARD™ production capabilities with advanced graphite materials to deliver specification-ready solutions to mission-critical markets.